Lista de obras -

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

scientific article published on 18 December 2019

A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma

artículo científico publicado el 1 de julio de 2011

Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells

artículo científico publicado en 2016

Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw

artículo científico publicado en 2020

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.

artículo científico publicado en 2018

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

artículo científico publicado en 2016

Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw

artículo científico publicado en 2019

Changes in Serum Interleukin-8 and sRAGE Levels in Multiple Myeloma Patients

artículo científico publicado en 2020

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies

artículo científico publicado en 2020

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies

scientific article published on 01 May 2016

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient

artículo científico publicado en 2017

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma

artículo científico publicado en 2019

Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management

artículo científico publicado en 2016

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

scientific article published on 19 June 2019

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials

artículo científico publicado en 2019

Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature

scientific article published on 25 September 2019

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2022

Immune checkpoint inhibitors in multiple myeloma: A review of the literature

scientific article published on 13 July 2020

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

artículo científico publicado en 2017

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

artículo científico publicado en 2017

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis

artículo científico publicado en 2019

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

scientific article published on 10 June 2019

Mitochondria-Targeted Antioxidant SkQ1 for Gammopathy-Related Corneal Damage

artículo científico publicado en 2019

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

artículo científico

Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules

scientific article published on 01 May 2020

Nanobodies and Cancer: Current Status and New Perspectives

artículo científico publicado en 2018

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era

scientific article published on 24 November 2020

New orally active proteasome inhibitors in multiple myeloma

artículo científico

Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology

artículo científico publicado en 2020

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS ⬇️

artículo científico publicado en 2019

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

scientific article published on 03 July 2019

Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects

artículo científico publicado en 2020

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies

artículo científico publicado en 2020

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age ⬇️

scholarly article

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease

artículo científico publicado en 2012

Relationship between mitofusin 2 and cancer

scientific article published on 27 December 2018

Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies

scientific article published on 29 August 2019

Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib

scientific article published on 01 September 2019

Telomerase and telomere biology in hematological diseases: A new therapeutic target

artículo científico publicado en 2017

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox

scientific article published on 22 October 2019

The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention

artículo científico publicado en 2018

The cancer stem cell hypothesis: a guide to potential molecular targets

artículo científico

The metabolomic signature of hematologic malignancies.

artículo científico publicado en 2016

Therapeutic potential of antagomiRs in haematological and oncological neoplasms

artículo científico publicado en 2020

Vaccination of multiple myeloma: Current strategies and future prospects

artículo científico

[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]

scientific article published on 01 July 2019

Lista de obras de

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma

Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells

Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw

Changes in Serum Interleukin-8 and sRAGE Levels in Multiple Myeloma Patients

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma

Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials

Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation

Immune checkpoint inhibitors in multiple myeloma: A review of the literature

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Mitochondria-Targeted Antioxidant SkQ1 for Gammopathy-Related Corneal Damage

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules

Nanobodies and Cancer: Current Status and New Perspectives

New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era

New orally active proteasome inhibitors in multiple myeloma

Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology

Preliminary Results of a Prospective Observational Study to Assess the Prevalence of Gaucher Disease in an Adult Population Affected By MGUS ⬇️

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age ⬇️

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease

Relationship between mitofusin 2 and cancer

Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies

Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib

Telomerase and telomere biology in hematological diseases: A new therapeutic target

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox

The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention

The cancer stem cell hypothesis: a guide to potential molecular targets

The metabolomic signature of hematologic malignancies.

Therapeutic potential of antagomiRs in haematological and oncological neoplasms

Vaccination of multiple myeloma: Current strategies and future prospects

[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]